C4 Therapeutics, Inc.
C4 Therapeutics, Inc. (CCCC) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 245 transactions totaling $17.2M, demonstrating a bearish sentiment with -$16.5M in net insider flow. The most recent transaction on Jan 16, 2026 involved a sale of 10,000 shares valued at $22.2K.
CCCC Insider Activity Summary
Who Is Buying CCCC Stock?
No significant insider buying has been recorded for CCCC in the recent period.
Who Is Selling CCCC Stock?
No significant insider selling has been recorded for CCCC in the recent period.
Is C4 Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CCCC is bearish with an Insider Alignment Score of 2/100 and a net flow of -$16.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CCCC Frequently Asked Questions
Understanding CCCC Insider Activity
Insider trading at C4 Therapeutics, Inc. (CCCC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading CCCC stock, having executed 245 transactions in the past 90 days. The most active insider is Elena Prokupets (Executive), who has made 30 transactions totaling $8.6M.
Related Tools
Track C4 Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CCCC file new Form 4 transactions